Recruiting studies: Paresthesia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks
NA · 1 location(s) · Pierre Fabre Dermo Cosmetique · NCT07014007 Neurological Recovery Following NOS-SACD
Phase N/A · 3 location(s) · Nottingham University Hospitals NHS Trust · NCT05714917 Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
Phase 2/Phase 3 · 1 location(s) · Bernardino Clavo, MD, PhD · NCT06799351 Depo-Medrol on Psoas After LLIF
Phase 4 · 1 location(s) · Hardeep Singh · NCT05929755 Mechanisms and Outcome-Prognostication for Paresthesia-based and -Free Spinal Cord Stimulation
NA · 1 location(s) · University Health Network, Toronto · NCT03852381 Local Vibration in Cervical Radiculopathy
NA · 1 location(s) · Bitlis Eren University · NCT06381011 Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)
Phase 2 · 1 location(s) · VM Therapeutics LLC · NCT07072468 Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
Phase 2/Phase 3 · 1 location(s) · Bernardino Clavo, MD, PhD · NCT06706544

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.